LEMAITRE VASCULAR INC·4

Jun 5, 5:37 PM ET

O'Connor John James 4

Research Summary

AI-generated summary

Updated

LEMAITRE VASCULAR (LMAT) Director John O'Connor Receives Award

What Happened

  • Director John O'Connor was credited with five dividend-equivalent awards on 2026-06-04, totaling 4.071 dividend-equivalent rights (0.466 + 0.558 + 0.76 + 0.86 + 1.427). Each was reported as an acquisition (code A) at $0.00 — these are derivative, non-cash accruals tied to existing restricted stock unit (RSU) and performance share unit (PSU) awards. The filing reports $0 cash value for these entries because they are dividend equivalents that vest proportionately with the underlying awards.

Key Details

  • Transaction date: 2026-06-04; Form 4 filed: 2026-06-05 (timely).
  • Reported entries: 0.466, 0.558, 0.76, 0.86, and 1.427 dividend-equivalent rights; price per unit reported $0.00.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnotes: each amount represents dividend-equivalent rights that accrued on prior awards and vest proportionately:
    • F1: accrued on RSU grant dated 12/8/2023
    • F2: accrued on PSU grant dated 12/8/2023
    • F3: accrued on RSU grant dated 12/6/2024
    • F4: accrued on PSU grant dated 12/6/2024
    • F5: accrued on RSU grant dated 12/10/2025
  • Transaction code: A = Award/Grant (derivative accruals), not a cash purchase or sale.

Context

  • Dividend-equivalent rights are bookkeeping credits that mirror dividends on underlying RSUs/PSUs and generally vest according to the schedule of the original awards; they are not immediate open-market purchases or sales. Such accruals are routine compensation mechanics and do not necessarily indicate a personal buy/sell decision by the insider.